BP Publishes new Draft Texts
Recommendation
Tuesday, 23 February 2027 9 .00 - 17.00 h
Integrating Compliance, Cost Transparency and Sustainable Value Creation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The British Pharmacopoeia (BP) has opened its next public consultation and feedback period for draft texts, covering 28 draft texts in total.
Six new monographs are included in this round:
- Naloxone Nasal Spray
- Rifampicin for Infusion
- Metronidazole Vaginal Gel
- Metronidazole Cream
- Memantine Oral Solution
- Hydrocortisone Tablets
The consultation also includes 22 revised draft texts:
- Thiotepa
- Thiotepa for Infusion
- Thiopental Injection
- Sodium fusidate ointment
- Rifampicin Oral Suspension
- Rifampicin Capsules
- Potassium Acetate Sterile Concentrate
- Perindopril Erbumine Tablets
- Oxazepam Tablets
- Metronidazole Oral Suspension
- Metronidazole Gel
- Furosemide Oral Solution
- Fluconazole Capsules
- Esomeprazole for Injection
- Cefuroxime for Injection
- Captopril Tablets
- Budesonide Pressurised Inhalation
- Budesonide Nebuliser Suspension
- Budesonide Inhalation Powder
- Budesonide Inhalation Powder, pre-metered
- Azathioprine Tablets
- Allopurinol Tablets
Comments can be submitted until 31 December 2026. All draft texts are available on the BP draft texts website , which also explains how to submit comments.
Related GMP News
05.11.2026Eurachem Publishes Webinar Recording on the Fitness for Purpose of Analytical Methods Guide
05.11.2026Recent Publications Highlighting Topics to be Discussed at PharmaLab 2026
05.11.2026Meet the AQCG Board Members at PharmaLab 2026
05.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines